Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 60Central Nervous System Neoplasms 39Brain Neoplasms 34Medulloblastoma 26Astrocytoma 15Rhabdoid Tumor 12Glioblastoma 12Ependymoma 12Sarcoma 10Glioma 9Testicular Neoplasms 8Oligodendroglioma 7Choroid Plexus Neoplasms 7Teratoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive, Peripheral 6Gliosarcoma 6Testicular Germ Cell Tumor 5Retinoblastoma 5Neuroectodermal Tumors, Primitive 5Neoplasms 5Lymphoma 5Recurrence 4Ovarian Neoplasms 4Ganglioneuroblastoma 4Familial ependymoma 4Carcinoma, Renal Cell 4Spinal Cord Neoplasms 3Rhabdomyosarcoma 3Osteosarcoma 3

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lambert-Eaton Myasthenic Syndrome × Etoposide × CNS × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡